Platelet Phospholipids and Stypven Clotting Time

L. L Hovmand; K Brøns; J Gormsen

doi:10.1055/s-0038-1653560

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1969; 21(03): 463-471
DOI: 10.1055/s-0038-1653560

Originalarbeiten - Original Articles - Travaux Originaux

Schattauer GmbH

Platelet Phospholipids and Stypven Clotting Time

L. L Hovmand Ph.D.

¹Institute of Experimental Research in Surgery, University of Copenhagen and Coagulation Laboratory, Medical Department, Sundby Hospital, Copenhagen, Denmark

,

K Brøns M.D.

¹Institute of Experimental Research in Surgery, University of Copenhagen and Coagulation Laboratory, Medical Department, Sundby Hospital, Copenhagen, Denmark

,

J Gormsen M.D.

¹Institute of Experimental Research in Surgery, University of Copenhagen and Coagulation Laboratory, Medical Department, Sundby Hospital, Copenhagen, Denmark

› Author Affiliations

Abstract

Summary

1. Phospholipids in the thrombocytes were studied in 16 healthy individuals, 18 patients with hepatic cirrhosis and 11 patients suffering from a variety of illnesses which are generally considered to be connected with thrombocytopathy.

2. In patients with hepatic cirrhosis the total amount of phospholipids was significantly lower: 8 (µg ± 2 µg lipid P per 10⁹ platelets compared to 12 (µg ± 2 (µg lipid P per 10⁹ platelets in healthy individuals.

3. The percentage composition of the phospholipids was the same for healthy individuals as for the diseased persons.

4. Decrease in platelet factor 3 activity as estimated by a modified stypven clotting time has been demonstrated using the thrombocytes from the patients suffering from hepatic cirrhosis whereas the activity was normal in uremic patients tested. The decreased clotting activity might partly be due to the reduced total amount of phospholipids. Surface active agents exert a much more profound reduction in clotting activity of phospholipids. It is concluded, that surface charge of phosphatide micelles determines their clotting activity more than concentration of all or a single phospholipid.

Full Text

References

References
1 Altschuler G, Marcus AaJ, Ullman H. L. Platelets and platelet phosphatides in uraemia. Blood 16: 1439-1446 1966;
2 Barkhan P, Silver M. J. Biological activities of human platelets: Biochemical physiological and clinical aspects. Prog. Hemat 03: 170-202 1962;
3 Bartlett G. R. Phosphorus assay in column chromatography. J. biol. Chem 234: 466-472 1959;
4 Born G. V. R. Changes in the distribution of phosphorus in platelet rich plasma during clotting. Biochem. J 68: 695-703 1958;
5 BrØns K, Gormsen J. Studies on platelet factor 3 activity. Scand. J. Haemat 05: 300-312 1968;
6 Cullum G, Cooney D. P, Schrier S. L. Familial thrombocytopenic thrombocytopathy. Brit. J. Haemat 13: 147-159 1967;
7 Daemen F. J. M, van ArJcel G, Hart H. G, van der Drift G, van der Deenen L. L. M. Activity of synthetic phospholipids in blood coagulation. Thrombos. Diathes. haemorrh. (Stuttg) 13: 194-217 1965;
8 Ferguson J. H, Marcus AaJ., Robinson A. J. Purified platelet phospholipids and blood coagulation. Blood 22: 19-32 1963;
9 Folch J, Less M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J. biol. Chem 226: 497-503 1957;
10 Hölmer G. Personal communication. 1968
11 Karaca M, Stefanini M. Chemical analysis of platelets from patients with congenital and acquired thrombocytopathy with special reference to phospholipids. J. Lab. clin. Med 67: 229-245 1966;
12 Marcus AaJ., Zucker M. B. The Physiology of Blood Platelets. Grune and Stratton, Inc; New York and London: 1965
13 Marcus JAa, Zucker-Franklin D, Safier L. B, Ullman H. L. Studies on human platelets and membranes. J. clin. Invest 45: 14-28 1966;
14 Papahadjopoulos D, Hougie C, Hanahan D. J. Influence of surface charge on clot promoting. Proc. Soc. exp. Biol. (N. Y.) 111: 412-419 1962;
15 Shinowara G. Y. The nature of the lipoprotein of human platelets and erythrocytes. In: Johnson S. A, Monto R. W, Rebuck J. W, Horn Jr. R. C. eds. Blood Platelets. Little, Brown and Co; Boston: 1961: 347-356.
16 Skidmore W. D, Entenman C. Two-dimensional thin-layer chromatography of rat liver phosphatides. J. Lipid Res 03: 471-475 1962;
17 Skipski V. P, Peterson R. F, Barclay M. Separation of phosphatidyl ethanolamine, phosphatidyl serine, and other phospholipids by thinlayer chromatography. J. Lipid Res 03: 467-470 1962;
18 Skipski V. P, Peterson R. F, Sanders J, Barcley M. Thinlayer chromatography of phospholipids using silica gel without calcium sulfate binder. J. Lipid Res 04: 227-230 1963;
19 Stahl E. Thin-Layer-Chromatography. Springer; Berlin, Göttingen, Heidelberg: 1965
20 Surgenor D. M, Wallach D. F. H. Biophysical aspects of platelet reaction mechanisms in clotting. In Johnson S. A, Monto R. W, Rebuck J. W, Horn Jr. R. C. eds. Blood Platelets. Little, Brown and Co; Boston: 1961: 289-302.
21 Troup S. B, Marinetti G. V, Swisher S. N. Thromboplastic factors in platelets and red cells: observation of their chemical structure and function in vitro coagulation. J. clin. Invest 39: 342-351 1960;
22 Wagner H, Hörhammer L, Wolf P. Dünnschichtchromatographie von phosphatiden und glykolipiden. Biochem. Z 334: 175-184 1961;
23 Zucker M. B, Borelli J. Changes in platelet adenosine triphosphate concentration and phosphate distribution during viscous metamorphosis and clot retraction. In Johnson S. A, Monto R. W, Rebuck J. W, Horn Jr. R. C. eds. Blood Platelets. Little, Brown and Co; Boston: 1961: 383.